{# max-image-preview:large is what makes an article eligible for the big-image card in Google Discover — without it Google may only show a thumbnail. #} {# ── Google Preferred Sources ──────────────────────────────────────────── Readers who mark us as a preferred source get our fresh articles prioritised in Top Stories, Discover and Google News. Only domain- and subdomain-level sites are eligible — blog.alfafinder.com qualifies, a /news/ subdirectory would not. #}

Gland Pharma — Latest News

Every announcement Gland Pharma has filed with the exchanges that we have reported, newest first. Each story links the original filing.

NSE: GLAND BSE: 543245 Pharmaceuticals & Biotechnology 2 stories

Price

₹2601

Market Cap

₹42,907.84 Cr

Revenue TTM

₹6,430.65 Cr

P/E (TTM)

41.77×

Sector 44.55×

Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.

Product Launched · 1 New Order · 1
New Order

Gland Pharma Secures Strategic CDMO Order Worth ₹902.5 Crore from Global Pharma Major

Gland Pharma signs a strategic CDMO partnership with a global pharmaceutical company for sterile injectables, projecting an annualized revenue of ₹90…
Product Launched

Gland Pharma Launches USFDA Approved Sugammadex Injection in 1.6 Billion Dollar US Market

Gland Pharma launches USFDA-approved Sugammadex Injection vials, targeting a USD 1.6 billion US market for the reversal of surgical neuromuscular blo…

Track Gland Pharma in real time

ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Gland Pharma files something material.

Start Free — 15-day trial
{# ── Promo popup — fires 5s after first page load per session. NEVER fires for visitors arriving from a search engine: a full-viewport overlay on a news article is an intrusive interstitial, and Google News policy is explicit that promotional material must not exceed the content. Direct, social and referral traffic still sees it. ─────────── #}